The health risks associated with smoking are well known, and so it’s not surprising that smoking after a CML diagnosis adds to the burden of illness in a somewhat indirect way. However, the most recent study suggests that smoking may have harmful effects on the biology underlying CML
The experience of living with chronic myelogenous leukemia has undergone a sea-change over the past two decades. The advent of a daily pill to suppress CML has meant that most people can now maintain their lifestyle and live a normal lifespan.
Recent studies have indicated that about 1 in 5 people with CML have problems with adherence, i.e. taking their medication as directed by their doctor (Okumura and colleagues. Pharm Pract 2015;13:559; Trivedi and colleagues. J Manag Care Spec Pharm 2014;20:1006-1015). There are many r
Tyrosine kinase inhibitors (TKIs, e.g. Gleevec, Tasigna, Sprycel, Bosulif, Iclusig) transformed the treatment of CML when they were introduced at the beginning of the 21st century. These medications target the leukemia gene that induces white blood cells to proliferate, effectively su
One of the most common fears expressed by cancer survivors is the fear that their disease will progress. But few studies have looked at whether this same fear is a cause of distress for people living with CML. In contrast to other cancers, CML is highly treatable with TKIs (tyrosine